Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2008
10/30/2008US20080268065 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
10/30/2008US20080268054 Dermal derived human stem cells and compositions and methods thereof
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268019 Synthetic polymeric component and a biological polymeric component; porous, biodegradable, biocompatible; wound healing, tissue regeneration
10/30/2008US20080267971 Antibodies Directed to Angiopoietin-2 and Uses Thereof
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267949 Peptides capable of binding to serum proteins
10/30/2008US20080267948 Croos-B Structure Binding Compounds
10/30/2008US20080267930 Biological Materials and Uses Thereof
10/30/2008US20080267920 Monoparamunity inducers based on attenuated rabbit myxomaviruses
10/30/2008US20080267901 Biocompatible Polymer Networks
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267874 Targeted Neuronal And Glial Human Embryonic Stem Cell Line
10/30/2008US20080267873 Aqueous injection buffer containing sodium chloride, calcium chloride, potassium chloride in the preparation of a RNA injection solution for increasing RNA transfer, RNA translation in a host organism
10/30/2008CA2721739A1 Drug combination and its use in the treatment of muscle loss
10/30/2008CA2683534A1 Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985634A1 Modulators of p-selectin glycoprotein ligand 1
10/29/2008EP1985311A1 Agent for targeting drug to cerebral neuron
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985306A2 TRX1 antibody and uses therefor
10/29/2008EP1985297A1 Carboxylic acid compound and use thereof
10/29/2008EP1985293A1 Method for producing denatured substance of lactalbumin
10/29/2008EP1984001A1 Fixed-dose association of phytate and zinc
10/29/2008EP1983982A1 Drug combinations
10/29/2008EP1506195B1 Non-nucleoside reverse transcriptase inhibitors
10/29/2008EP1505959B1 Use of edg receptor binding agents in cancer
10/29/2008EP1474067B1 One dose vaccination with i mycoplasma hyopneumoniae /i
10/29/2008EP1425264B1 C2-disubstituted indane-1-ol systems and their use as medicaments
10/29/2008EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives
10/29/2008EP1406698B1 Lipoxin analogs as novel inhibitors of angiogenesis
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008EP1263739B9 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid
10/29/2008EP1222208B1 Polypeptide derivatives of parathyroid hormone (pth)
10/29/2008EP1144592B1 Substrate for cell growth
10/29/2008EP1076564B1 Compositions for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/29/2008EP1054693B1 Inhibitors of complement activation
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008CN101296914A Derivative having PPAR agonistic activity
10/29/2008CN101296693A Endurance improver
10/29/2008CN101293080A Sweat suppressing plaster
10/29/2008CN101293039A Compound essential oil for refreshing oneself, and eliminating fatigue
10/29/2008CN101292998A Use of fly-maggot powder in anti-fatigue, anti-senescence and anti-adiposity health care function aspects
10/29/2008CN101292976A Medicament combination containing 1,8-eudesmin and flavanones, and uses thereof
10/29/2008CN100429206C Benzoxazine derivatives as 5-HT6 modulators and uses thereof
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/29/2008CN100428934C Application of cumarin kind compound in preparation of medicine for inducing nerve stem cell orienting differentiation
10/29/2008CN100428932C TGF-alpha expression inhibitors
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442788 Nucleosides; peptide nucleic acids; orientation of sugar governs positioning of antisense molecule
10/28/2008US7442784 For regulation of gene expression
10/28/2008US7442763 Kidney diseases
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442704 Amide derivatives
10/28/2008US7442703 Piperidine derivatives useful as CCR5 antagonists
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442541 biologically pure strain of Aureobasidium pullulans isolated from a food source; culturing in a medium containing saccharides as a carbon source; has resistance to the antibiotic cycloheximide
10/28/2008US7442526 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008US7442142 Automatic transmission
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2442227C Ccr5 antagonists useful for treating aids
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2373868C Compositions comprising organosiloxane resins for delivering oral care substances
10/28/2008CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
10/28/2008CA2300876C Naphthoquinone derivatives as hiv matrix protein tyrosine position 29 pocket binders
10/28/2008CA2225924C Recombinant mistletoe lectin
10/28/2008CA2200568C Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
10/23/2008WO2008127795A2 External animal layer sanitation using bacteriophage
10/23/2008WO2008127138A1 Composition for decelerating the ageing in the organism and for extending the life time thereof and the use of said composition
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008126898A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008WO2008126831A1 Atropisomer of pyrrole derivative
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126693A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
10/23/2008WO2008126638A1 Anti-histamine substance and method for production thereof
10/23/2008WO2008125820A1 Combination therapy comprising azd2171 and azd6244 or mek-inhibitor ii
10/23/2008WO2008124878A1 Non-steroidal compounds
10/23/2008WO2008067121A3 Methods of treating cognitive impairment and dementia
10/23/2008WO2008007113A3 Pharmaceutical combinations
10/23/2008US20080262415 topical administration of a biocompatible composition comprising a neurostimulatory and/or neuroprotective macrolide, and doxycycline or azithromycin, for a duration sufficient to enhance viability, confer protection, reduce scarring, degeneration of neural cells and/or stimulate sensation
10/23/2008US20080262286 using methyl arachidonyl fluorophosphonate (MAFP) and arachidonyl trifluoromethyl ketone (AACOCF3) as cytosolic phospholipase A2 (cPLA2) antagonist, a vector encoding a cytosolic phospholipase antagonist; tumor growth suppression; ionizing radiation; small interfering RNA targeted to cPLA2 gene product
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1564